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ABSTRACT
Background: Sweating plays a key role in skin homeostasis, including antimicrobial and moisturizing effects,
and regulation of skin surface pH. Impaired axon reflex-mediated (AXR) sweating has been observed in pa-
tients with atopic dermatitis (AD). However, the mechanism of such abnormal sudomotor axon reflex remains to
be revealed.
Methods: To investigate this mechanism, sudomotor function was analyzed using a quantitative sudomotor
axon reflex test (acetylcholine iontophoresis) in patients with AD (n = 26) and healthy volunteers (n = 12). Cor-
relation between sudomotor function and certain background factors, including Spielberger State Trait Anxiety
Inventory score, Severity Scoring of Atopic Dermatitis (SCORAD) score, number of circulating eosinophils, and
serum concentrations of thymus and activation-regulated chemokine and immunoglobulin E radioimmunosorb-
ent test, was validated.
Results: Latency time was significantly prolonged in AD (p = 0.0352), and AXR sweating volume (mg0-5
min) was significantly lower in AD patients than in healthy controls (p = 0.0441). Direct sweating volume (mg0-
5 min) was comparable in AD patients and healthy controls. A significant correlation between the evaluation re-
sults of quantitative sudomotor axon reflex tests and certain background factors was not observed. The latency
time in non-lesioned and lesioned areas for AD patients versus continuous anxiety value in the Spielberger
State Trait Anxiety Inventory and the AXR versus SCORAD showed significant correlations (p = 0.0424, p =
0.0169, and p = 0.0523, respectively).
Conclusions: Although the number of study subjects was little, abnormal AXR sweating in patients with AD
was observed. Correlative analysis suggests possible involvement of continuous anxiety and the immune sys-
tem in such abnormal sudomotor function.
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INTRODUCTION
Sweating plays a key role in skin homeostasis, with
antimicrobial1,2 and moisturizing effects,3 and in the
regulation of skin surface pH.4 Certain data also sug-
gest that impaired sweating contributes to the patho-
genesis of atopic dermatitis (AD). It has been re-
ported that showering at school reduces the severity
of AD.5 Since it is known that the pHs of both sweat
and the skin surface increase with time,6 old sweat
might cause skin barrier dysfunction and promote in-
fection, which are regarded as exacerbating factors
for AD.4,7 In contrast, decreased sweating might
cause dry skin and exacerbate skin symptoms in AD.
In fact, acetylcholine (ACh)-mediated sweating is im-
paired in patients with AD.3 Furthermore, a signifi-
cant increase in ACh tissue content8 and reduced
ACh receptor expression levels9 in lesioned skin of
AD patients suggest that the cholinergic system of
the skin is modulated in AD. This belief assumes that
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Fig.　1　Equipment and procedures for QSART. (A) The 
measurement sensor for sweating volume (sweat capsule: 
middle compartment) is surrounded by the outer compart-
ment with a sponge-like device for iontophoresis. (B) Exam-
ple of how the sweat capsule is used. Electrode for iontopho-
resis is placed on the wrist. (C) Sweat volume-measuring 
machine (lower right, SKINOS SKD-2000, Nagano, Japan), 
digital analyzer of measured sweat volume (upper right), and 
power source of iontophoresis (left). (D) Illustration of 
QSART.
a modulated ACh system might affect sudation in AD;
however, ACh-induced direct sweat volume does not
appear to be affected.3 Looking at an altered ACh sys-
tem in the local skin alone cannot explain abnormal
sweating responses in AD patients.
To assess the reproducibility of sudomotor func-
tion in AD patients, a quantitative sudomotor axon re-
flex test (QSART)10 was performed. To elucidate the
mechanisms of altered ACh-induced sweating, we
evaluated the correlation between the measurements
of sweating and certain clinical factors, including
Spielberger State Trait Anxiety Inventory (STAI)
score, serum concentrations of immunoglobulin E ra-
dioimmunosorbent test (IgE-RIST) and thymus and
activation-regulated chemokine (TARC), and the
number of circulating eosinophils.
METHODS
SUBJECTS
Quantitative Sudomotor Axon Reflex Test
(QSART)
Examination was performed based on the method es-
tablished by Lee et al..10 Briefly, the subjects were
asked to remain quiet for 60 min before undergoing
QSART in a hospital outpatient clinic at constant tem-
perature (20℃) and humidity (60%). The multicom-
partmental sweat capsule used in QSART consists of
two independent compartments (Fig. 1A). ACh (100
mgml) iontophoretically applied to the skin from the
outer compartment stimulates the underlying sweat
glands directly (DIR sweating), while the glands of
the skin in the central compartment of the capsule
are activated indirectly via an axon reflex (AXR sweat-
ing; Fig. 1B-D). The central compartment of the cap-
sule serves as the site for AXR sweat volume meas-
urement during the 5 min of iontophoresis. Data for
DIR sweating were obtained over the subsequent 5
min.
Sweat onset time, that is, the latency period for
sweating after current loading (latency time), and
sweat volume over 5 min were measured, and the
area under the sweating curve was calculated from 0-
5 min for AXR sweating and from 6-11 min for DIR
sweating. As for the measurement of DIR sweating
volume, a few cases with immeasurable volumes
were omitted from the Table 1.
Study Design
This study was approved by the Institutional Review
Board of Osaka University Hospital. Measurements
of serum TARC and total IgE (radioimmunoassay)
concentrations and eosinophil number were per-
formed on all study subjects after they signed an in-
formed consent form and provided written and oral
information to the study physicians. Patients with AD
fulfilled diagnostic criteria by both Hanifin and Rajka
11 and the Japanese Dermatological Association.12 As
a result, 26 adult patients with AD [male : female; 11 :
15, 43.58 ± 15.3 years old; mean ± standard deviation
(SD)] and 12 healthy volunteers (male : female; 5 : 7,
32 ± 5.8 years old; mean ± SD) were admitted into the
study. The severity of AD was assessed with Severity
Scoring of Atopic Dermatitis (SCORAD).13 STAI, de-
signed and standardized by Spielberger et al., was
used to evaluate anxiety.14
Laboratory Methods
Fasting blood samples were drawn from the subjects.
After serum separation, levels of TARC and IgE and
eosinophil number were measured by enzyme-linked
immunosorbent assay, radioimmunoassay, and visual
evaluation, respectively.
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Table　1　Correlation between clinical data and altered sudomotor function
STAI 
(trait anxiety)
STAI 
(state anxiety) SCORAD TARC IgE-RIST Eosinophil Age
Latency NL n = 26
r = 0.4266
p = 0.0424
n = 26
r = 0.3628
p = 0.0970
n = 26
r = -0.1736
p = 0.3964
n = 26
r = -0.2252
p = 0.2790
n = 26
r = 0.03887
p = 0.8537
n = 26
r = -0.04125
p = 0.8414
n = 26
r = 0.1529
p = 0.4655
L n = 26
r = 0.5273
p = 0.0169
n = 26
r = -0.05509
p = 0.8028
n = 26
r = 0.04284
p = 0.8389
n = 26
r = -0.03478
p = 0.8718
n = 26
r = 0.3256
p = 0.1123
n = 26
r = -0.02849
p = 0.8901
n = 26
r = -0.0805
p = 0.7022
AXR NL n = 26
r = -0.3114
p = 0.1481
n = 26
r = -0.1381
p = 0.5298
n = 26
r = 0.4575
p = 0.0099
n = 26
r = 0.2010
p = 0.3248
n = 26
r = -0.01775
p = 0.9314
n = 26
r = -0.2664
p = 0.1883
n = 26
r = -0.1249
p = 0.5520
L n = 26
r = 0.08509
p = 0.6995
n = 26
r = -0.07144
p = 0.7520
n = 26
r = 0.02314
p = 0.9107
n = 26
r = 0.1096
p = 0.5939
n = 26
r = 0.04424
p = 0.8301
n = 26
r = 0.05705
p = 0.7774
n = 26
r = -0.07954
p = 0.7055
DIR NL n = 21
r = -0.04935
p = 0.8508
n = 21
r = 0.08784
p = 0.7374
n = 21
r = 0.1272
p = 0.5826
n = 21
r = -0.09078
p = 0.6956
n = 21
r = 0.2742
p = 0.2291
n = 21
r = -0.007898
p = 0.9708
n = 26
r = -0.1006
p = 0.6324
L n = 21
r = 0.2880
p = 0.2624
n = 21
r = 0.2293
p = 0.3759
n = 21
r = -0.2654
p = 0.2449
n = 21
r = 0.1043
p = 0.6440
n = 21
r = 0.1299
p = 0.5646
n = 21
r = 0.1289
p = 0.5393
n = 26
r = 0.1781
p = 0.3943
NL, non-lesional; L, lesional.
Case number (n), Pearson r (r), and p value (two-tailed) (p).
RESULTS
ACh-INDUCED SWEATING VOLUME IN HEALTHY
AND AD SUBJECTS
ACh-induced DIR and AXR mediated sweating vol-
ume were measured in healthy and AD subjects.
First, comparison of AXR or DIR-mediated sweating
volume between healthy and AD subjects (non-
lesioned area) was performed (Fig. 2A). AXR-
mediated sweating volume in AD patients (non-
lesioned area) was significantly lower than that in
healthy subjects. On the one hand, DIR-mediated
sweating volume in AD patients was comparable to
that of healthy subjects (Fig. 2A). Next, comparison
between lesioned and non-lesioned skin in subjects
with AD was performed (Fig. 2B). AXR-mediated
sweating volume in lesioned skin was significantly
lower than that in non-lesioned skin. These results in-
dicate that AXR-, but not DIR-mediated sweating, is
attenuated in AD subjects (Fig. 2C).
LATENCY TIME FOR ACh-INDUCED SWEATING
IN HEALTHY AND AD SUBJECTS
Time to onset of sweating after the start of ACh ionto-
phoresis (latency time) was measured (Fig. 3). La-
tency time in subjects with AD (non-lesioned skin)
was significantly prolonged compared with healthy
subjects (p = 0.0352, unpaired t test) (Fig. 3A). Unex-
pectedly, there was no difference between non-
lesioned and lesioned skin in AD subjects (Fig. 3B),
suggesting that abnormal ACh-induced sweating re-
sponses are commonly found in AD subjects regard-
less of the presence or absence of dermatitis.
RELATED BACKGROUND FACTORS TO AL-
TERED SUDOMOTOR FUNCTION
To explore the mechanisms of abnormal ACh-
induced sweating in AD subjects, the relationships
between measurements of sweating and certain clini-
cal factors, such as the STAI score, SCORAD score,
number of circulating eosinophils, and serum concen-
trations of TARC and IgE-RIST, were verified. As
shown in the Table 1, trait anxiety vs. latency time
(both non-lesioned and lesioned skin) and SCORAD
vs. AXR-mediated sweating volume in non-lesioned
skin showed significant positive correlations. Other
parameters did not have a significant correlation with
measurements of sweating.
DISCUSSION
The involvement of sweating in the pathogenesis of
AD has become a major topic of discussion. As men-
tioned above, recent studies have organized the
pathogenic involvement of sweat to include not only a
barrier function but also the exacerbation of AD.1,3,5,9
However, the cause and mechanism of abnormal
ACh-induced axon reflex sweating in AD patients re-
main unclear.3 Here, we validated the reproducibility
of QSART in AD subjects. As a result, decreased axon
reflex-mediated sweating volume and prolonged la-
tency time in subjects with AD were confirmed. It
was noteworthy that these findings were also ob-
served in non-lesioned skin of AD patients. This phe-
nomenon implies that local inflammation alone can-
not explain the impaired sudomotor function in AD.
Although there is no direct evidence supporting this
Kijima A et al.
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Fig.　2　Measurements of ACh-induced sweating volume in 
healthy and AD subjects. (A) AXR- and DIR-related sweating 
volume in healthy volunteers (gray) and non-lesioned areas 
of AD patients (black). *p < 0.05, unpaired t test. (B) Com-
parison of AXR-mediated sweating volume between non-le-
sioned and lesioned skin in patients with AD. **p < 0.01, 
paired t test. (C) Comparison of DIR-mediated sweating vol-
ume between non-lesioned and lesioned skin in patients with 
AD.
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Fig.　3　Examination outcomes for latency time of ACh-in-
duced sweating in healthy and AD subjects. (A) Compari-
sons of latency time between non-lesioned and lesioned skin 
in patients with AD. *p < 0.05, paired t test. (B) Comparisons 
of latency time between non-lesioned and lesioned skin in 
patients with AD.
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hypothesis, ACh has been reported to accumulate in
lesioned skin in AD patients.8 Thus, it might be sup-
posed that ACh receptor down-regulation in the skin
of those with AD might occur via ACh saturation. To
explore the cause of this abnormity, this report fo-
cused on certain clinical parameters.
Interestingly, trait anxiety was positively correlated
to latency time in both non-lesioned and lesioned ar-
eas of AD. Although, there was few evidence support-
ing the relationship between trait anxiety and ACh,
Sklan et al. reported that the higher the trait anxiety,
the lower the enzyme activity of acethylcholin-
esterase (AChE).15 Furthermore, previous studies
had suggested that AD is a skin disease associated
with increased anxiety levels.16,17 Though this might
be just a mere coincidence, if enzymatic activity of
AChE decreased in AD, the dysregulation might
cause the anxious mood and the accumulation of
ACh, confirming past findings.8,16,17 Thus, the enzy-
matic activity of AChE in AD was considered worthy
of attention. In a measurement of sweat volume, de-
spite marked reduction in AXR-mediated sweating
volume in AD subjects, DIR-mediated sweating vol-
ume was preserved. Therefore, it could be proposed
that malfunction of sudomotor nerve might lead to
decrease in the AXR-mediated sweating response in
AD (Fig. 4). Such an anomaly in the sweating re-
sponse in AD patients might lead to the development
of dry skin (Fig. 4).
The other positive correlation was found between
SCORAD and AXR-mediated sweating volume in non-
lesioned areas (Table 1). It is difficult to explain why
these factors correlate with each other, despite no
definite correlation between SCORAD and AXR-
mediated sweating volume in lesioned areas. How-
ever, we treated increased AXR-mediated sweating
volume in non-lesioned area the same as in cases of
compensatory hyperhidrosis, which is occasionally
observed in cases of invasive treatments of hyper-
hidrosis.18 Thus, it might be speculated that damaged
sympathetic nerves in lesioned skin had relatively in-
creased the sweating volume in surrounding non-
lesioned areas.
Regarding the correlation between SCORAD and
trait or state anxiety level, there was no correlation
(data not shown), similar to the previous report.17
This result led us to think that high anxiety level was
not just result of disease severity. Yet, in this study,
there were limitations in the statistical strategy that
had assessed the relation between a variety of pri-
mary endpoints. Thus, we deemed it necessary to
consider that poor statistical correlation in evaluative
Sweating and High Anxiety in Atopic Dermatitis
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Fig.　4　Proposed association of abnormal sweating to dry 
skin and unique characteristics of AD. Dark gray arrows indi-
cated the confi rmatory results of this study. Light gray arrows 
indicated the tentative theory.
ATOPIC DERMATITIS
DRY SKIN/BARRIER DYSFUNCTION
being prone to anxiety
malfunction of sudomotor
nerves
decrease in axon reflex-mediated sweating volume
delayed response to Ach
consequences did not mean no relation to each other.
In conclusion, this study revealed abnormal sweat
responses in subjects with AD, and the higher the
trait anxiety, the slower the sweat response. In con-
trast, previous report indicated rinsing old sweat on
skin surface reduced severity of AD.5 Put it all to-
gether, although there are arguments both for and
against the involvement of “sweat” in the exacerba-
tion of AD, our results suggest that studies of “sweat”
should be divided into “sweating response” and “after
sweating.” From this point of view, we should give
AD patients psychosomatic treatments and lifestyle
guidance to stimulate adequate sweating. Addition-
ally, we must endorse the importance of washing
away sweat daily.5
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